WEBCAST

WEBCAST Thursday, September 13th at 4:40 PM EDT


Lyon (France), September 13, 2018 – ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances inside red blood cells, today announced that Gil Beyen will present and host investor meetings at the 2018 Morgan Stanley Global Healthcare Conference.

An archived version will be available within approximately two hours of the live presentation and can be accessed at the same location for 60 days.

Conference call on Tuesday, September 11th at 2:30 pm CEST/8:30 am EST


ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it will host a second quarter 2018 conference call and webcast on Tuesday, September 11, 2018, at 2:30 PM CEST/8:30 AM EST to discuss operational highlights.

Conference Details:

  • Webcast Date: September 11th, 2018
  • Presentation Time: 2:30 pm CEST/8:30 am EST

The call is accessible via the below teleconferencing numbers, followed by the Conference ID#: 4983808#:

USA/Canada: +1 (833) 818-6807
France: +33 176748988
United-Kingdom: +44 2031070289
International Dial-In Number: +1 (409) 350-3501

The webcast can be followed live online via the link: https://edge.media-server.com/m6/p/z452iwaf.

An archived replay of the call will be available for 7 days by dialing + 1 800 585 8367, Conference ID: 4983808#. An archive of the webcast will be available on ERYTECH’s website, under the “Investors” section at http://investors.erytech.com.

Link to slideshow

Conference call on Monday, June 25th at 2:30 pm CET/8:30 am EDT


ERYTECH Confirms Strategic Focus of Eryaspase on Solid Tumors and Ceases Development in Acute Lymphoblastic Leukemia

Conference Call Details:

  • ERYTECH management will hold a conference call on Monday, June 25, 2018 at 02:30pm CET / 08:30am EDT. Gil Beyen, Chairman and CEO, Eric Soyer, CFO and COO and Iman El-Hariry, CMO will be available for a Q&A session.

The call is accessible via the below teleconferencing numbers, followed by the Conference ID#: 6590689#:

USA/Canada: +1 833 818 6807
France: +33 176748988
Belgium: +32 24003547
Switzerland: +41 445802606
Spain: +34 914142503
Germany: +49 6922224728
Finland: +358 972519310
United-Kingdom: +44 2031070289
Sweden: +46 856619361
Netherlands: +31 207075547

An archived replay of the call will be available for 7 days by dialing + 1 855 859 2056, Conference ID: 6590689#.

Link to slideshow

WEBCAST Wednesday, June 6th at 11:00 AM EDT / 5:00 CET


ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that Chief Executive Officer, Gil Beyen, will present at the Jefferies Global Healthcare Conference on Wednesday, June 6, 2018 at The Grand Hyatt, in New York City.

Conference Details:

  • Conference: Jefferies Global Healthcare Conference
  • Date: Wednesday, June 6th, 2018
  • Presentation Time: 11:00 AM EDT / 5:00 CET
The webcast can be followed live online via the link: http://wsw.com/webcast/jeff113/eryp/.

Following, the live webcast, an archive of the presentation will be available on the company website for 30 days, under the “Investors” section at investors.erytech.com.

WEBCAST Tuesday, May 15th at 2:30 PM CEST / 8:30 AM EST


ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it will host its 2018 first quarter conference call and webcast on Tuesday, May 15, 2018, at 2:30 PM CEST/8:30 AM EST to discuss operational highlights.

Conference Details:

  • Webcast Date: May 15th, 2018
  • Presentation Time: 2:30 PM CEST / 8:30 AM EST

The call is accessible via the below teleconferencing numbers, followed by the Conference ID#: 3498017#:

USA/Canada: +1 833 818 6807
United-Kingdom: +44 2031070289
Switzerland: +41 445802606
Germany: +49 6922224728
France: +33 176748988
Belgium: +32 24003547
Sweden: +46 856619361
Finland: +358 972519310
Netherlands: +31 207075547
Spain: +34 914142503

The webcast can be followed live online via the link: https://edge.media-server.com/m6/p/wq3dzxoy.

An archived replay of the call will be available for 7 days by dialing + 1 800 585 8367, Conference ID: 3498017#. An archive of the webcast will be available on ERYTECH’s website, under the “Investors” section at http://investors.erytech.com.

Link to slideshow

WEBCAST Wednesday, March 14th at 9:20 AM EDT / 14:20 CET


ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that Chief Executive Officer, Gil Beyen, will present at the Cowen and Company 38th Annual Health Care Conference on Wednesday, March 14, 2018 at The Marriott Copley Place, in Boston, MA.

Conference Details:

  • Conference: Cowen and Company 38th Annual Health Care Conference
  • Date: March 14, 2018
  • Presentation Time: 9:20 AM EDT / 14:20 CET

The webcast can be followed live online via the link: http://wsw.com/webcast/cowen46/eryp/.

 

Following, the live webcast, an archive of the presentation will be available on the company website for 30 days, under the “Investors” section at investors.erytech.com.

WEBCAST Tuesday, March 13, 2018, at 1:30 PM CET/8:30 AM EST


ERYTECH to Host Fourth Quarter and Full Year 2017 Conference Call and Business Update

Conference Details:

  • Webcast Date: March 13, 2018
  • Presentation Time: 1:30 PM CET/8:30 AM EST

The webcast can be followed live online via the link:

https://edge.media-server.com/m6/p/qa7wj9by

The call is accessible via the below teleconferencing numbers, followed by the Conference ID#: 7997444#:

USA: +1 8338186807
United-Kingdom: +44 02031070289
Switzerland: +080 0836508
Germany: +49 06922224728
France: +33 0176748988
Belgium: +32 024003547
Sweden: +46 0856619361
Finland: +358 0972519310
Netherlands: +31 0207075547
Spain: +34 914142503

An archived replay of the call will be available for 7 days by dialing (US & Canada): +1 833 818 6807, (UK): +44(0) 203 107 0289, (France): +33(0)1 726 74 89 88, (Spain): +34 91412503, Conference ID # 7997444#.

An archive of the webcast will be available on ERYTECH’s website, under the “Investors” section at investors.erytech.com.

Link to slideshow

WEBCAST Monday, December 11th at 10:00 AM EST/ 16:00 PM CET


ERYTECH to webcast Top-Line results of Phase 2B Study of Eryaspase for the Treatment of AML

Conference Details:

  • Webcast Date: December 11, 2017
  • Presentation Time: 10:00 AM EST/ 16:00 PM CET

The webcast can be followed live online via the link:

https://edge.media-server.com/m6/p/o2fziqc6

Investors and analysts can also participate by accesing via the following teleconferencing numbers:

USA: +1 833 8186807 United-Kingdom: +080 00323836
Switzerland: +080 0561782 Germany: +080 01815287
France: +080 5081485 Belgium: +080 073308
Sweden: +020 798505 Finland : +080 0412874
Netherlands: +080 00200089

Password: 6983889

Link to slideshow

WEBCAST Wednesday,November 15th at 2:00 PM GMT/ 9:00 AM ET


ERYTECH to Webcast Presentation at Jefferies 2017 London Healthcare Conference

Conference Details:

  • Conference: Jefferies Global Healthcare Conference
  • Date: November 15, 2017
  • Presentation Time: 2:00 PM GMT/ 9:00 AM ET

The webcast can be followed live online via the link

Jefferies Global Healthcare Conference webcast

 

Link to slideshow

WEBCAST Tuesday,November 14th at 2:30 PM CET/8:30 AM EST


Erytech Pharma today announced that it will host a Third Quarter 2017 conference call and webcast on Tuesday, November 14, 2017, at 2:30 PM CET/8:30 AM EST to discuss operational highlights.

USA: +1 6467224907
United-Kingdom: +44 2030432440
Switzerland: +41 225809022
Germany: +49 69222229031
France: +33 172001510
Belgium: +32 24029640
Sweden: +46 850334664
Finland: +358 942599700
Netherlands: +31 107138194
Spain: +34 914142021


Confirmation Code: 95373849#


The webcast can be followed live online via the link

http://www.anywhereconference.com?UserAudioMode=DATA&Name=&Conference=135311448&PIN=95373849

 

Following the live call, a replay will be available for 90 days. To listen to the replay, please dial:
USA: +1 877 64 230 18
United-Kingdom: +44 20 33 67 94 60
France: +33 1 72 00 15 00
Spain: +34 917896320

Confirmation Code: 311448#

Link to slideshow

Top